Cargando…

Diagnostic Accuracy of the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC): An Institution Experience

The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) is a standardized system which is used to classify results of thyroid fine-needle aspiration (FNA). This system is used to evaluate and determine which patients should get thyroid surgery. It was created in order to reduce the number o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rai, Karima, Park, Joseph, Gokhale, Shamika, Irshaidat, Fatima, Singh, Gurdeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665099/ https://www.ncbi.nlm.nih.gov/pubmed/38021084 http://dx.doi.org/10.1155/2023/9615294

Ejemplares similares

The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC): A report of 2,781 cases in a Chinese population
por: Zhu, Yanli, et al.
Publicado: (2020)

Diagnostic accuracy of Bethesda system for reporting thyroid cytopathology: an institutional perspective
por: Naz, Samreen, et al.
Publicado: (2014)

Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) – An 8-year tertiary center experience in Thailand
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2018)

Histopathological Review of Diagnostic Categories of the Bethesda System for Reporting Thyroid Cytopathology – An Institutional Experience of 5 Years
por: Upadhyaya, Paricha, et al.
Publicado: (2019)

A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: An institutional experience
por: Arul, P., et al.
Publicado: (2015)

The Diagnostic Performance of Thyroid US in Each Category of the Bethesda System for Reporting Thyroid Cytopathology
por: Park, So Yoon, et al.
Publicado: (2016)

Thyroid Nodules Cytopathology Applying the Bethesda System with Histopathological Correlation
por: Zarif, Hawazen A., et al.
Publicado: (2018)

The Bethesda System for Reporting Thyroid Cytopathology: A Cytohistological Study
por: Anand, Bakiarathana, et al.
Publicado: (2020)

Thyroid Cytopathology Reporting by the Bethesda System: A Two-Year Prospective Study in an Academic Institution
por: Mehra, Payal, et al.
Publicado: (2015)

Fine Needle Aspiration of Thyroid Nodules Using the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience in a Rural Setting
por: Guo, Aili, et al.
Publicado: (2017)

Cytological diagnosis of pediatric thyroid nodule in perspective of the Bethesda System for Reporting Thyroid Cytopathology
por: Pantola, Chayanika, et al.
Publicado: (2016)

The Bethesda system for reporting thyroid cytopathology in Colombia: Correlation with histopathological diagnoses in oncology and non-oncology institutions
por: Melo-Uribe, Mario Alexander, et al.
Publicado: (2015)

Reproducibility of the Bethesda System for Reporting Thyroid Cytopathology: A Methodological Issue
por: Naderi, Mehdi, et al.
Publicado: (2019)

The Bethesda System for Reporting Thyroid Cytopathology: Validating at Tribhuvan University Teaching Hospital
por: Acharya, Kunjan, et al.
Publicado: (2021)

A Different Perspective on Evaluating the Malignancy Rate of the Non-Diagnostic Category of the Bethesda System for Reporting Thyroid Cytopathology: A Single Institute Experience and Review of the Literature
por: Gunes, Pembegul, et al.
Publicado: (2016)

Reproducibility of “The Bethesda System for Reporting Thyroid Cytopathology:” A Retrospective Analysis of 107 Patients
por: Awasthi, Pragati, et al.
Publicado: (2018)

ODP481 Frequency and outcomes of reporting Bethesda class III thyroid cytopathology- An integrated health network's experience
por: Dantey, Kossivi, et al.
Publicado: (2022)

Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience
por: Kim, Milim, et al.
Publicado: (2018)

Real-world EUROCRINE(®) registry data challenge the reliability of Bethesda cytopathology for thyroid surgery indication
por: Staubitz, Julia I., et al.
Publicado: (2021)

FNAC accuracy in diagnosis of thyroid neoplasms considering all diagnostic categories of the Bethesda reporting system: A single-institute experience
por: Hajmanoochehri, Fatemeh, et al.
Publicado: (2015)

Correlation between Thyroid Imaging Reporting and Data System and Bethesda System of Reporting of Thyroid Cytopathology of Thyroid Nodule: A Single Center Experience
por: Biswas, Ananya, et al.
Publicado: (2020)

The 2023 Bethesda system for reporting thyroid cytopathology: novi sub sole, subdivision is no more debatable, in thyroidology
por: Sengul, Ilker, et al.
Publicado: (2023)

Non-invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) Lowers the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology Diagnostic Categories
por: Al-Maghrabi, Hatim, et al.
Publicado: (2022)

The Use of the Bethesda System for Reporting Thyroid Cytopathology in Korea: A Nationwide Multicenter Survey by the Korean Society of Endocrine Pathologists
por: Kim, Mimi, et al.
Publicado: (2017)

The prevalence and associated predictors for Bethesda III–VI for reporting thyroid cytopathology in Royal Commission Hospital, Kingdom of Saudi Arabia
por: Alyousif, Hussain, et al.
Publicado: (2022)

Correlation between Ultrasound-based TIRADS and Bethesda System for Reporting Thyroid-cytopathology: 2-year Experience at a Tertiary Care Center in India
por: Periakaruppan, Gokulakrishnan, et al.
Publicado: (2018)

Evaluation of thyroid lesions by fine-needle aspiration cytology based on Bethesda system for reporting thyroid cytopathology classification among the population of South Bihar
por: Bhartiya, Richa, et al.
Publicado: (2016)

Diagnostic Thyroidectomy May Be Preferable in Patients With Suspicious Ultrasonography Features After Cytopathology Diagnosis of AUS/FLUS in the Bethesda System
por: Lee, Yong Sang, et al.
Publicado: (2015)

Bethesda System for Reporting Thyroid Cytopathology: A three-year study at a tertiary care referral center in Saudi Arabia
por: Al Dawish, Mohamed Abdulaziz, et al.
Publicado: (2017)

Clinico-cytopathological subcategorization in thyroid nodules of atypia of undetermined significance/follicular lesion of undetermined significance using the TIRADS and Bethesda classifications
por: Babajani, Amirhesam, et al.
Publicado: (2023)

Evaluation of thyroid nodules classified as Bethesda category III on FNAC
por: Garg, Shiwani, et al.
Publicado: (2017)

Reproducibility of Cytomorphological Diagnosis and Assessment of Risk of Malignancy of Thyroid Nodules Based on the Bethesda System for Reporting Thyroid Cytopathology: A Tertiary Cancer Center Perspective
por: Panda, Sasmita, et al.
Publicado: (2022)

Pancreaticobiliary tract cytology: Journey toward “Bethesda” style guidelines from the Papanicolaou Society of Cytopathology
por: Layfield, Lester James, et al.
Publicado: (2014)

Incidence and Malignancy Rates of Diagnoses in the Bethesda System for Reporting Thyroid Aspiration Cytology: An Institutional Experience
por: Park, Ji Hye, et al.
Publicado: (2014)

Classification of thyroid fine-needle aspiration cytology into Bethesda categories: An institutional experience and review of the literature
por: Alshaikh, Safa, et al.
Publicado: (2018)

Evaluation of thyroid nodules classified as Bethesda category III on cytology and their malignancy rate: An institutional experience
por: Almahari, Sayed Ali, et al.
Publicado: (2019)

BRAF V600E mutation and the Bethesda System for Reporting Thyroid Cytopathology of fine-needle aspiration biopsy for distinguishing benign from malignant thyroid nodules
por: Sheng, Danli, et al.
Publicado: (2021)

Verification bias is common in cytopathology studies on diagnostic accuracy
por: Schmidt, Robert L.
Publicado: (2014)

Comment on: "Evaluating treatment options in managing thyroid nodules with indeterminate cytology of TBSRTC in thyroidology: addendum aut non?"
por: Sengul, Ilker, et al.
Publicado: (2022)

Multimodality Molecular Imaging (FDG-PET/CT, US Elastography, and DWI-MRI) as Complimentary Adjunct for Enhancing Diagnostic Confidence in Reported Intermediate Risk Category Thyroid Nodules on Bethesda Thyroid Cytopathology Reporting System
por: Basu, Sandip, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3cebfsb0qepln6u87u8ps17f0n